UK becomes first country to approve Pfizer-BioNtech COVID-19 vaccine


Team Udayavani, Dec 2, 2020, 1:10 PM IST

 

London: The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, paving the way for mass vaccinations against the deadly novel coronavirus.

The British regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), says the jab, which claims to offer up to 95 per cent protection against COVID-19 illness, is safe for roll out.

The joint vaccine, produced by American pharmaceutical giant Pfizer and German biotech firm BioNTech, had recently claimed trials suggested it works well in people of all ages, races and ethnicities.

The UK government had asked the MHRA to look into the data to clear it for use if it meets “robust” standards of quality, safety, and effectiveness.

The UK is expected to receive a total of 40 million doses by the end of 2021, enough to vaccinate up to a third of the population, with the majority of doses anticipated in the first half of next year.

“If approval is granted, the NHS (National Health Service) will be ready to deliver. The NHS has vast experience in delivering widespread vaccination programmes and an enormous amount of work has taken place to ensure we have the logistical expertise, transport and workforce to roll out a vaccine according to clinical priority, at the speed at which it can be manufactured,” UK Health Secretary Matt Hancock had said last month.

The UK government stressed that the COVID-19 vaccine will only be authorised for supply by the UK’s independent regulator if it meets strict standards of quality, safety, and effectiveness, and if they are satisfied the vaccine can be consistently manufactured.

The MHRA is the UK’s independent regulator, hailed as a globally recognised institution for requiring the highest standards for quality, safety and effectiveness.

The vaccine will be manufactured in BioNTech’s German sites, as well as Pfizer’s manufacturing site in Belgium.

The UK government said it remains confident that the cold supply chain needed to distribute the Pfizer/BioNTech vaccine will not cause any problems or delays. When the vaccine is stored in a fridge, it has an effective life of up to five days at temperatures of 2 to 8 degrees, which will allow it to be easily stored at distribution centres.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

MS Dhoni gets treatment for knee pain in Ranchi village, doctor sits under a tree

Bengaluru: Woman from Brahmavar ends life after killing her daughter

Good rainfall: Cropping activity picks up in twin districts

Higgs boson: 10 years after its discovery, why this particle could unlock new physics beyond the standard model

Strong earthquake kills 5 in southern Iran

Karavali coast: Crime news roundup

Bommai reiterates promise to develop Bengaluru into city with amenities of int’l standards


Related Articles More

12 US lawmakers urge Biden to hold India accountable in WTO for its ‘trade-distorting practices’

Strong earthquake kills 5 in southern Iran

US announces $820M in Ukraine aid, including missile systems

PM Modi and Russian President Putin discuss state of global energy & food markets

COVID cases up by more than 30 per cent in Britain last week

MUST WATCH

How to earn God’s grace?

NEW BULLETIN 01-07-2022

Heavy Rain Mallar Urdu school Damage

Heavy rain at kaup area

Banana cultivation : Success story of a farmer


Latest Additions

MS Dhoni gets treatment for knee pain in Ranchi village, doctor sits under a tree

Bengaluru: Woman from Brahmavar ends life after killing her daughter

Good rainfall: Cropping activity picks up in twin districts

12 US lawmakers urge Biden to hold India accountable in WTO for its ‘trade-distorting practices’

D K Shivakumar planned criminal conspiracy with aides to hide cash: ED

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.